Pfizer said $11.6B to buy Biohaven Pharma in the biggest deal by the wealthy drugmaker since 2016 aimed at strengthening…
Read More »Pfizer
Pfizer trimmed its 2022 earnings guidance, despite reporting better-than-bottom-and-higher Q1 results thanks to better sales of its coronavirus vaccine
Read More »Shares of the major manufacturers of Covid vaccines fell after the unprecedented wave of the outbreak of infections with the…
Read More »Pfizer sees record revenue in 2022 as it expects to sell up to $32B worth of COVID-19 vaccine doses and…
Read More »Pfizer said it will buy drug developer Arena Pharmaceuticals for $6.7M, adding a promising lineup of candidate therapies for stomach…
Read More »Pfizer announced that it raised full-year sales forecast for COVID-19 vaccine by 7.5% to $36B, coinciding with signing new contracts…
Read More »Analysts and healthcare investors believe that major drugmakers Pfizer, BioNTech and Moderna will raise billions of dollars in booster doses…
Read More »Pfizer said it plans to seek full US approval for its COVID-19 vaccine with its German partner BioNTech by the…
Read More »Pfizer expects that sales of the Coronavirus vaccine may exceed $15B, knowing that the company aims to produce about 2B…
Read More »AstraZeneca's COVID-19 vaccine may receive emergency use approval from UK regulators and be released in the first week of 2021
Read More »